title: Posttetanic potentiation and fade in the response to tetanic and train-of-four stimulation during succinylcholine-induced block.
abstract: We designed this study to confirm anecdotal observations that neuromuscular block after a single administration of succinylcholine is characterized by fade to train-of-four (TOF) or tetanic stimulation, as well as posttetanic potentiation. This prospective, randomized, 2-center observational study involved 100 patients. Patients were allocated to 1 of 5 groups and received 0.1, 0.3, 0.5, 0.75, or 1.0 mg/kg succinylcholine during propofol/fentanyl/nitrous oxide anesthesia. Neuromuscular function was monitored by TOF using mechanomyography. At 10%-20% spontaneous recovery of the first twitch of TOF, the mode of stimulation was changed from TOF to 1-Hz single-twitch stimulation followed by a tetanic stimulus (50 Hz) for 5 s. Three seconds later, the single twitch (1 Hz) was applied again for approximately 30 s followed by TOF stimulation until full recovery of the TOF response. Succinylcholine-induced neuromuscular block had the following characteristics: 1) twitch augmentation before twitch depression, which was seen more frequently in patients given smaller doses (0.1 and 0.3 mg/kg) than in those given larger doses (0.5-1.0 mg/kg); 2) TOF fade during onset and recovery of the block; 3) tetanic fade; and 4) and posttetanic potentiation. Posttetanic potentiation was related to the pretetanic twitch height but was not related to the dose of succinylcholine administered. Some characteristics of Phase II block were detectable during onset and recovery from doses of succinylcholine as small as 0.30 mg/kg. Posttetanic potentiation and fade in response to train-of-four and tetanic stimuli are characteristics of neuromuscular block after bolus administration of different doses of succinylcholine.
  
  
  CONCLUSIONS
  Posttetanic potentiation and fade in response to train-of-four and tetanic stimuli are characteristics of neuromuscular block after bolus administration of different doses of succinylcholine. We also conclude that some characteristics of a Phase II block are evident from an initial dose (i.e., as small as 0.3 mg/kg) of succinylcholine.
authors.affiliation: *Department of Anesthesia, University of Iowa College of Medicine, Iowa City, Iowa; and †Department of Anesthesiology, The Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, New York.
authors.forename: Mohamed
authors.initials: M
authors.lastname: Naguib
authors.forename: Cynthia A
authors.initials: CA
authors.lastname: Lien
authors.forename: John
authors.initials: J
authors.lastname: Aker
authors.forename: Rudolfo
authors.initials: R
authors.lastname: Eliazo
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D016001:Confidence Intervals; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D009213:Myography / Q000379:methods; D009407:Nerve Block / Q000379:methods*; D011446:Prospective Studies; D013390:Succinylcholine / Q000008:administration & dosage* / Q000009:adverse effects; D013746:Tetany / Q000139:chemically induced* / Q000503:physiopathology
chemical_list: D013390:Succinylcholine